Top

Published in:

Open Access 01-12-2010 | Commentary

Emerging evidence-based physical rehabilitation for Multiple Sclerosis - Towards an inventory of current content across Europe

Authors: Kamila Rasova, Peter Feys, Thomas Henze, Hans van Tongeren, Davide Cattaneo, Johanna Jonsdottir, Alena Herbenova

Published in: Health and Quality of Life Outcomes | Issue 1/2010

Abstract

In Europe, theoretical approaches to physical therapy and rehabilitation in multiple sclerosis often appear significantly different. While there is general agreement that rehabilitation plays an important role in maintaining and improving function in persons with multiple sclerosis, no consensus exists on what may be the most effective approach to achieve the best possible functionality within an individual's limitations.

The objective of this paper is to initiate an analysis of currently applied physical interventions for people with multiple sclerosis throughout Europe during inpatient or outpatient rehabilitation programs. A study of the content of rehabilitation may show presently performed treatment methods revealing the basic considerations that nowadays guide clinicians implicitly or explicitly in the treatment of persons with multiple sclerosis. Following this first step, comparative studies can be set up.

Thompson AJ: Symptomatic management and rehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry 2001,71(Suppl 2):22–27.

Henze T, Rieckmann P, Toyka KV: Symptomatic treatment of Multiple Sclerosis. Eur Neurol 2006, 56: 78–105. 10.1159/000095699PubMedCrossRef

Khan F, Turner-Stokes L, Ng L, Kilpatrick T: Multidisciplinary rehabilitation for adults with multiple sclerosis. Cochrane Database Syst Rev 2007, (2):CD006036.

Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, et al.: AFFIRM Investigators. A randomised, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2006,354(9):899–910. 10.1056/NEJMoa044397PubMedCrossRef

Kozak T, Havrdova E, Pitha J, et al.: High dose immunosupressive therapy with PBCP support in the treatment of poor risk multiple sclerosis. Bone Marrow Transplant 2000,25(5):525–531. 10.1038/sj.bmt.1702180PubMedCrossRef

Goodkin DE, Rudick RA, et al.: Low dose (7,5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol 1995, 37: 30–40. 10.1002/ana.410370108PubMedCrossRef

Barkhof F, Hommes OR, Scheltens P, Valk J: Quantitative MRI changes in gadolinium-DPTA enhancement after high-dose intravenous methylprednisolone in multiple sclerosis. Neurology 1991, 41: 1219–1222.PubMedCrossRef

Wade D: Rehabilitation research-time for a change of focus. The Lancet Neurology 2002,1(4):209.. 10.1016/S1474-4422(02)00095-9PubMedCrossRef

Richardson D: Physical therapy in spasticity. Eur J Neurol 2002,9(Suppl 1):17–22. 10.1046/j.1468-1331.2002.0090s1017.xPubMedCrossRef

10.

Nadeau SE: A paradigm shift in neurorehabilitation. Lancet Neurol 2002,1(2):126–130. 10.1016/S1474-4422(02)00044-3PubMedCrossRef

11.

Pelletier J, Audoin B, Reuter F, Ranjeva JP: Plasticity in MS: from functional imaging to rehabilitation. Int MS J 2009, 16: 26–31.PubMed

12.

Khan F, Pallant JF, Brand C, Kilpatrick TJ: Effectiveness of Rehabilitation Intervention in persons with Multiple sclerosis: A Randomized Controlled Trial. J Neurol Neurosurg Psychiatry 2008,79(11):1230–1235. 10.1136/jnnp.2007.133777PubMedCrossRef

13.

Freeman JA, Langgdon DW, Hobart JC: The impact of inpatient rehabilitation on progressive multiple sclerosis. Ann Neurol 1997, 2: 236–244. 10.1002/ana.410420216CrossRef

14.

Freeman JA, Langdon DW, Hobart JC, Thompson AJ: Inpatient rehabilitation in multiple sclerosis: do the benefits carry over into the community? Neurology 1999,52(1):50–56.PubMedCrossRef

15.

Kidd D, Thompson AJ: Prospective study of neurorehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997,62(4):423–424. 10.1136/jnnp.62.4.423PubMedCentralPubMedCrossRef

16.

Dalgas U, Stenager E, Ingemann-Hansen T: Multiple sclerosis and physical exercise: recommendations for the application of resistance, endurance and combined training. Mult Scler 2008, 14: 35–53. 10.1177/1352458507079445PubMedCrossRef

17.

Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G: Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev 2005, (1):CD003980.

18.

Romberg A, Virtanen A, Ruutiainen J: Long-term exercise improves functional impairment but not quality of life in multiple sclerosis. J Neurol 2005,252(7):839–845. 10.1007/s00415-005-0759-2PubMedCrossRef

19.

Romberg A, Virtanen A, Ruutiainen J, Aunola S, Karppi SL, Vaara M, et al.: Effects of a 6-month exercise program on patients with multiple sclerosis: a randomized study. Neurology 2004,63(11):2034–2038.PubMedCrossRef

20.

Mostert S, Kesselring J: Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis. Mult Scler 2002, 8: 161–168. 10.1191/1352458502ms779oaPubMedCrossRef

21.

World Health Organization: International Classification of Functioning, Disability and Health (ICF). Pocket-sized Book 2001. ISBN-13 9789241545440

22.

Kesselring J, Coenen M, Cieza A, Thompson A, Kostanjsek N, Stucki G: Developing the ICF Core Sets for multiple sclerosis to specify functioning. Mult Scler 2008,14(2):252–254. 10.1177/1352458507082615PubMedCrossRef

23.

Khan F, Pallant JF: Use of the International Classification of Functioning, Disability and Health (ICF) to identify preliminary comprehensive and brief core sets for multiple sclerosis. Disabil Rehabil 2007,29(3):205–213. 10.1080/09638280600756141PubMedCrossRef

24.

Motl RW, McAuley E: Pathways between physical activity and quality of life in adults with multiple sclerosis. Health Psychol 2009,28(6):682–689. 10.1037/a0015985PubMedCrossRef

25.

Petajan JH, Gappmaier E, White AT: Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurology 1996, 39: 432–441. 10.1002/ana.410390405CrossRef

26.

EMSP: Code of Good Practice in MS, May 2007 - revised in March 2008.

27.

Haigh R, Tennant A, Biering-Sørensen F, Grimby G, Marincek C, Phillips S, Ring H, Tesio L, Thonnard JL: The use of outcome measures in physical medicine and rehabilitation within Europe. J Rehabil Med 2001,33(6):273–8. 10.1080/165019701753236464PubMedCrossRef

28.

Moret-Hartman M, Reuzel R, Grin J, van der Wilt GJ: Participatory Workshops are Not Enough to Prevent Policy Implementation Failures: An Example of a Policy Development Process Concerning the Drug Interferon-beta for Multiple Sclerosis. Health Care Anal 2008,16(2):161–175. 10.1007/s10728-007-0069-1PubMedCentralPubMedCrossRef

29.

Flachenecker P, Khil L, Bergmann S, Kowalewski M, Pascu I, Pérez-Miralles F, Sastre-Garriga J, Zwingers T: Development and pilot phase of a European MS register. J Neurol 2010, in press.

30.

Prodinger B, Weise AP, Shaw L, Stamm TA: A Delphi study on environmental factors that impact work and social life participation of individuals with multiple sclerosis in Austria and Switzerland. Disabil Rehabil 2010,32(3):183–95. 10.3109/09638280903071883PubMedCrossRef

31.

Kwakkel G: Towards integrative neurorehabilitation science. Physiother Res Int 2009,14(3):137–146. 10.1002/pri.446PubMedCrossRef

32.

Hutchinson B, Forwell SJ, Bennett S, Brown T, Karpatkin H, Miller D: Toward a Consensus on Rehabilitation Outcomes in MS: Gait and Fatigue. Report of a CMSC Consensus Conference, November 28–29, 2007. Int J MS Care 2009, 11: 67–78.CrossRef

33.

Gijbels D, Alders G, Van Hoof E, Charlier C, Roelants M, Broekmans T, Thijs H, Eijnde BO, Feys P: Predicting habitual walking performance in MS: relevance of capacity and self-report measures. Multiple Sclerosis 2010,16(5):618–26. 10.1177/1352458510361357PubMedCrossRef

34.

Wiles CM, Newcombe RG, Fuller KJ, Shaw S, Furnival-Doran J, Pickersgill TP, et al.: Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis. J Neurol Neurosurg Psychiatry 2001,70(2):174–179. 10.1136/jnnp.70.2.174PubMedCentralPubMedCrossRef

35.

Solari A, Filippini G, Gasco P, Colla L, Salmaggi A, La Mantia L, et al.: Physical rehabilitation has a positive effect on disability in multiple sclerosis patients. Neurology 1999,52(1):57–62.PubMedCrossRef

36.

Rasova K, Brandejsky P, Havrdova E, Zalisova M, Foubikova B: Comparison of the influence of different rehabilitation programs on clinical spirometric and spiroergometric parameters in patients with multiple sclerosis. Multiple Sclerosis 2006, 12: 227–234. 10.1191/135248506ms1248oaPubMedCrossRef

37.

Di Fabio RP, Soderberg J, Choi T, Hansen CR, Schapiro RT: Extended outpatient rehabilitation: its influence on symptom frequency, fatigue, and functional status for persons with progressive multiple sclerosis. Arch Phys Med Rehabil 1998,79(2):141–146. 10.1016/S0003-9993(98)90290-8PubMedCrossRef

38.

Lord SE, Wade DT, Halligan PW: A comparison of two physiotherapy treatment approaches to improve walking in multiple sclerosis: a pilot randomized controlled study. Clin Rehabil 1998,12(6):477–486. 10.1191/026921598675863454PubMedCrossRef

39.

Freeman D, Harris M: The philosophy of science and theories of case management. In Case management for mentally ill patients. Edited by: Harris M, Bergman H. Harwood Accademic Publishers; 1993:1–5.

40.

Elola J, Daponte A, Navarro V: Health indicators and the organization of health care systems in western Europe. Am J Public Health 1995,85(10):1397–401. 10.2105/AJPH.85.10.1397PubMedCentralPubMedCrossRef

41.

van Doorslaer E, Wagstaff A, van der Burg H, Christiansen T, De Graeve D, Duchesne I, Gerdtham UG, Gerfin M, Geurts J, Gross L, Häkkinen U, John J, Klavus J, Leu RE, Nolan B, O'Donnell O, Propper C, Puffer F, Schellhorn M, Sundberg G, Winkelhake O: Equity in the delivery of health care in Europe and the US. J Health Econ 2000,19(5):553–83. 10.1016/S0167-6296(00)00050-3PubMedCrossRef

42.

Perkins MB, Jensen PS, Jaccard J, Gollwitzer P, Oettingen G, Pappadopulos E, Hoagwood KE: Applying theory-driven approaches to understanding and modifying clinicians' behavior: what do we know? Psychiatr Serv 2007,58(3):342–8. 10.1176/appi.ps.58.3.342PubMedCrossRef

43.

Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR: Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999,282(15):1458–65. 10.1001/jama.282.15.1458PubMedCrossRef

44.

Mauksch LB, Dugdale DC, Dodson S, Epstein R: Relationship, communication, and efficiency in the medical encounter: creating a clinical model from a literature review. Arch Intern Med 2008,168(13):1387–95. 10.1001/archinte.168.13.1387PubMedCrossRef

45.

Faissner A, Kettenmann H, Trotter J: A critical review of contemporary therapies. In Comprehensive Human Physiology. Edited by: Greger R, Windhorst U. Springer-Verlag, Berlin; 1996:96–108.

46.

Umphred DA, El-din D: Introduction. In Theoretical Foundations for Clinical Practice Neurological Rehabilitation. Fourth edition. Edited by: Umphred DA. Mosby, Inc., St. Luis Missouri; 2001:3–31.

47.

Kolar P: Facilitation of Agonist-Antagonist Co-activation by Reflex Stimulation methods. In Rehabilitation of the Spine. Edited by: Craig Liebenson. Lippincott Williams & Wilkins; 2007.

48.

Wolf SL, Winstein CJ, Miller JP, Taub E, Uswatte G, Morris D, Giuliani C, Light KE, Nichols-Larsen D: Effect of constraint-induced movement therapy on upper extremity function 3 to 9 months after stroke: the EXCITE randomized clinical trial. JAMA 2006, 296: 2095–2104. 10.1001/jama.296.17.2095PubMedCrossRef

49.

Wolf SL, Blanton S, Baer H, Breshears J, Butler AJ: Repetitive task practice: a critical review of constraint-induced movement therapy in stroke. Neurologist 2002,8(6):325–338. 10.1097/00127893-200211000-00001PubMedCentralPubMed

50.

Levin MF, Kleim JA, Wolf SL: What do motor "recovery" and "compensation" mean in patients following stroke? Neurorehabil Neural Repair 2009,23(4):313–319.PubMedCrossRef

51.

Shumway-Cook A, Woollacott MH: Motor control. In Translating research into clinical praktice. Third edition. Lippincott Wiliams and Wilkins; 2006.

Title: Emerging evidence-based physical rehabilitation for Multiple Sclerosis - Towards an inventory of current content across Europe
Authors: Kamila Rasova
Peter Feys
Thomas Henze
Hans van Tongeren
Davide Cattaneo
Johanna Jonsdottir
Alena Herbenova
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: Health and Quality of Life Outcomes / Issue 1/2010
Electronic ISSN: 1477-7525
DOI: https://doi.org/10.1186/1477-7525-8-76

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Emerging evidence-based physical rehabilitation for Multiple Sclerosis - Towards an inventory of current content across Europe

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Factors associated with psychological and behavioral functioning in people with type 2 diabetes living in France

Quality of Life as reported by children and parents: a comparison between students and child psychiatric outpatients

Physicians' knowledge of health-related quality of life and perception of its importance in daily clinical practice

Health related quality of life after extremely preterm birth: a matched controlled cohort study

Identifying type and determinants of missing items in quality of life questionnaires: Application to the SF-36 French version of the 2003 Decennial Health Survey

Measurement invariance of the kidney disease and quality of life instrument (KDQOL-SF) across Veterans and non-Veterans